Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Medicines Law & Policy
18 POSTS
0 COMMENTS
Proposed TRIPS waiver a hollow diplomatic compromise with little practical impact
Medicines Law & Policy
-
April 12, 2022
The US NIH will share technology with WHO to fight the pandemic
Medicines Law & Policy
-
March 3, 2022
A second Covid-19 treatment will now be made available through the Medicines Patent Pool
Medicines Law & Policy
-
November 16, 2021
Medicines Patent Pool signs first Covid-19 licence agreement with Merck Sharp & Dohme. Others...
Medicines Law & Policy
-
October 27, 2021
The EU proposed Covid waivers of certain TRIPS rules are mostly meaningless
Medicines Law & Policy
-
October 14, 2021
Advanced Purchase Agreements for Covid-19 Vaccines: Do they ensure Global Public Good?
Medicines Law & Policy
-
July 21, 2021
US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a...
Medicines Law & Policy
-
May 6, 2021
BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery: a legitimate move...
Medicines Law & Policy
-
April 13, 2021
Ensuring that intellectual property rights aren’t a barrier to scaling-up: the remarkable example of...
Medicines Law & Policy
-
April 13, 2021
The European Commission says Covid-19 vaccines should be global public goods, but do their...
Medicines Law & Policy
-
January 28, 2021
1
2
Page 1 of 2